Showing results (181-190 of 250) with videos related to
Sort By:
Pageof 25
Virology|November 10, 2016
A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor siteAmira Zine El Abidine, Vjekoslav Tomaić, Rahima Bel Haj Rhouma, et al.Cancer Research|December 7, 2007
Epithelial-mesenchymal transition events during human embryonic stem cell differentiationAngela M Eastham, Helen Spencer, Francesca Soncin, et al.Circulation|July 30, 2017
In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal CellsFrancesca Bortolotti, Giulia Ruozi, Antonella Falcione, et al.Journal of Virology|December 16, 2011
Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus typesIris Cornet, Véronique Bouvard, Maria Saveria Campo, et al.The FEBS Journal|July 19, 2012
Human papillomaviruses and the specificity of PDZ domain targetingDavid Pim, Martina Bergant, Siaw S Boon, et al.Viruses|July 7, 2015
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to MalignancyKetaki Ganti, Justyna Broniarczyk, Wiem Manoubi, et al.Journal of Virology|April 13, 2026
Regulation of HPV-16 infection by ubiquitination of the L1 major capsid proteinOscar Trejo-Cerro, Martina Bergant Marušič, Patryk Wlodarczyk, et al.Cancer Gene Therapy|October 19, 2002
Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteinsKevin A Myers, Matthew G Ryan, Peter L Stern, et al.Molecular Cancer Therapeutics|December 17, 2002
Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumorsKate Mulryan, Matthew G Ryan, Kevin A Myers, et al.The Biochemical Journal|May 11, 2002
Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancerAndrew M Woods, Who W Wang, David M Shaw, et al.Pageof 25